Market trends, startup funding, enterprise adoption strategies, and how AI is disrupting traditional business models.
Silicon Valley dreamed of endless AI growth, powered by cheap energy and investor cash. Now, Iran's strait drama is spiking prices, exposing the boom's shaky foundations.
AI just ditched chatty sidekick mode for relentless worker bee. Karpathy's self-coding loops and China's agent frenzy signal the real shift.
Xoople's dropping $130 million on satellites promising AI-grade Earth data. Smart move or satellite-sized hype?
The AI gold rush has billionaires cutting out VCs to bet big on private startups. It's riskier than ever—and reeks of dot-com déjà vu.
Your next Alibaba order might arrive smarter, faster—thanks to a $53 billion AI war chest. But does this massive bet fix slowing growth or signal desperation?
OpenAI just pocketed $6.5 billion in its latest round, valuing the startup at $157 billion. But forget the hype—this signals AI's messy evolution into a power grid, where cash and compute crown the kings.
Anthropic just upsized its funding ask from $2B to $3.5B, hitting a $61.5B valuation. But with cheap Chinese models flooding the scene, why the frenzy?
Anthropic's dropping Mythos like it's hot— a beastly AI sniffing out ancient zero-days. But with leaks galore and feds circling, is this defense or deflection?
Picture a cubicle drone hitting 'send' on a desperate list of wins — only for AI to judge if it's enough to keep the job. Elon Musk's DOGE just turned bureaucracy into a high-stakes AI gauntlet.
Parked in a Walmart lot, Patrick Ciriello fired off his 1,000th job alert. Then LinkedIn pinged: AI trainer wanted. For desperate older techies, it's the gig that pays—while building their obsolescence.
Imagine economies turbocharged by AI, but only if we craft smart industrial policies now. This blueprint flips the script on opportunity and resilience.
Jensen Huang's on stage, grinning like it's 2017 all over again, promising AI will fix healthcare's mess. But after two decades watching this Valley circus, I'm wondering: does it ever deliver for patients, or just NVIDIA's bottom line?